Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Capricor Therapeutics revenue
Capricor Therapeutics's revenue is $22.3 million.
What is Capricor Therapeutics's revenue?
- Capricor Therapeutics's revenue growth from 2007 to 2024 is 21,862.98%.
- Capricor Therapeutics has 33 employees, and the revenue per employee ratio is $674,862.
- Capricor Therapeutics's peak quarterly revenue was $12.1M in 2023(q4).
- Capricor Therapeutics peak revenue was $25.2M in 2023.
- Capricor Therapeutics annual revenue for 2023 was 25.2M, 886.81% growth from 2022.
- Capricor Therapeutics annual revenue for 2024 was 22.3M, -11.55% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Capricor Therapeutics historical revenue
Capricor Therapeutics's peak revenue was $25.2M in 2023. The peak quarterly revenue was $12.1M in 2023(q4).
Capricor Therapeutics's revenue increased from $101.4k in 2007 to $22.3M currently. That's a 21,862.98% change in annual revenue.
Capricor Therapeutics annual revenue
Capricor Therapeutics annual revenue over time
| Fiscal year / year | Capricor Therapeutics revenue |
|---|---|
| 2011 | $1.4M |
| 2012 | $1.9M |
| 2013 | $503,233 |
| 2014 | $4.8M |
| 2015 | $5.5M |
| 2016 | $4.0M |
| 2017 | $2.7M |
| 2018 | $1.7M |
| 2019 | $1.0M |
| 2020 | $310,250 |
| 2021 | $244,898 |
| 2022 | $2.6M |
| 2023 | $25.2M |
| 2024 | $22.3M |
How accurately did Capricor Therapeutics' revenue projections match actual performance?
Capricor Therapeutics annual growth
Capricor Therapeutics saw the greatest revenue growth in 2011, when revenue increased by 1,235.8%.
Capricor Therapeutics had the lowest revenue growth in 2013, when revenue changed by -73.5%.
Capricor Therapeutics annual growth rate over time
| Year | Capricor Therapeutics growth |
|---|---|
| 2011 | 1236%↑ |
| 2012 | 40%↑ |
| 2013 | -73%↓ |
| 2014 | 851%↑ |
| 2015 | 15%↑ |
| 2016 | -28%↓ |
| 2017 | -33%↓ |
| 2018 | -37%↓ |
| 2019 | -40%↓ |
| 2020 | -69%↓ |
| 2021 | -21%↓ |
| 2022 | 942%↑ |
| 2023 | 887%↑ |
| 2024 | -12%↓ |
Capricor Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Capricor Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | $346,000 | $813,000 | $195,500 |
| 2012 | $195,500 | - | - | ($195.8K) |
| 2014 | $1.0M | $1.0M | $1.0M | $1.0M |
| 2015 | $1.0M | $912,881 | $913,692 | $911,970 |
| 2016 | $911,139 | $909,672 | $746,781 | $684,912 |
| 2017 | $880,808 | $996,462 | $260,771 | $528,299 |
| 2018 | $400,066 | $403,960 | $219,249 | $648,082 |
| 2019 | $230,504 | $410,353 | $142,071 | $222,100 |
| 2020 | $185,693 | $49,864 | $16,863 | $57,830 |
| 2021 | $40,816 | $204,082 | - | - |
| 2022 | - | - | $1.6M | $959,903 |
| 2023 | $3.0M | $3.9M | $6.2M | $12.1M |
| 2024 | $4.9M | $4.0M | $2.3M | $11.1M |
Capricor Therapeutics jobs nearby
Do you work at Capricor Therapeutics?
Did Capricor Therapeutics meet its revenue projections?
Capricor Therapeutics financial information
| Company Type | Public |
| Employees Number | 33 |
| Date Founded | 2005 |
| Headquarters | Beverly Hills, California |
| Number of Locations | 1 |
| Revenue | $22.3M |
| Net Income | -$29,019,532 |
| PE Ratio | -0.51 |
| Market Capitalization | $20.7M |
| Total Assets | $50,094,910 |
| Ticker | CAPR |
Capricor Therapeutics jobs you might like
Capricor Therapeutics financing
Capricor Therapeutics received early financing of $3.4M on 2009-07-08.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $3.4M | 07/2009 |
| Post Ipo Equity | $2M | 12/2010 |
| Post Ipo Equity | $6M | 04/2012 |
| Post Ipo Equity | $26.3M | 12/2013 |
| Post Ipo Equity | $10M | 02/2015 |
| Grant | $3.4M | 03/2016 |
| Grant | $2.4M | 09/2016 |
| Grant | $4.2M | 10/2016 |
| Post Ipo Equity | $3.7M | 05/2017 |
| Post Ipo Equity | $5.1M | 12/2019 |
Capricor Therapeutics investors
| Investors | Security type |
|---|---|
| Beechwood Ventures | Post Ipo Equity |
| CALMEDICA | Post Ipo Equity |
| Broadview Ventures Inc | Post Ipo Equity |
| Cedars Sinai | Post Ipo Equity |
| CureDuchenne Ventures | Post Ipo Equity |
| California Institute for Regenerative Medicine | Grant |
| US Department Of Defense | Grant |
| National Institutes of Health (NIH) | Grant |
Search for jobs
Capricor Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Capricor Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Capricor Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Capricor Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Capricor Therapeutics. The data presented on this page does not represent the view of Capricor Therapeutics and its employees or that of Zippia.
Capricor Therapeutics may also be known as or be related to CAPRICOR THERAPEUTICS INC., CAPRICOR THERAPEUTICS, INC., Capricor Therapeutics, Capricor Therapeutics Inc, Capricor Therapeutics Inc. and Capricor Therapeutics, Inc.